Mode
Text Size
Log in / Sign up
Phase 2 N=55 Randomized Single-blind Treatment

Fluoxetine Mitigation Mental Health Study for Patients With Musculoskeletal Trauma

Musculoskeletal Injury

Enrolled (actual)
55
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcome: Primary: BDI-II - Beck Depression Inventory-II — 11.4; 12.8; 9.6; 11.5 units on a scale

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
Fluoxetine (Drug); Calcium (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Florida
Primary completion
Feb 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
BDI-II - Beck Depression Inventory-II
11.4; 12.8; 9.6; 11.5; 8.1; 12.2
PRIMARY
BAI - Beck Anxiety Inventory
12.7; 11.5; 9.9; 12.5; 10.5; 10.8
PRIMARY
PSQI - Pittsburgh Sleep Quality Index
7; 9.4; 7.1; 7.3; 7.1; 6.6
PRIMARY
PSS-SR5 - PTSD Symptom Scale-Self-Report for DSM-5
21.9; 15.1; 15.9; 19.3; 14.8; 17.3
PRIMARY
PROMIS Social Isolation - Patient-Reported Outcomes Measurement Information System
43.7; 47.7; 45.9; 49; 50.8; 47.8
SECONDARY
PEG - Pain, Enjoyment of Life, and General Activity Scale
5.7; 4.9; 5.3; 6.1; 3.9; 4.2

Summary

Musculoskeletal trauma is one of the leading causes of disability in the United States and its negative quality of life impact extends beyond that of physical recovery. More than 50% of victims of musculoskeletal trauma suffer lasting mental health issues following their injury. These symptoms can develop across all spectrums of patients with a variety of injury severities. Previously, this research team developed a ten-step program with the aim of developing fostering coping mechanisms in trauma patients. We were unable to demonstrate a measurable benefit to their mental health or physical function. This has been mirrored in other studies as well; talk therapy and support groups are not a strong enough intervention for some patients. We hypothesize that a subset of the trauma population would benefit from medical treatment for their depressive and anxious symptoms in the early recovery period. Given the limited resources of mental health systems, it would be ideal for their surgical providers to be able to manage safely their post-injury mental health issues during their surgical follow up. This is a pragmatic pilot study to develop an effective, acceptable, time-limited treatment strategy that could be safely implemented by non-mental health care providers for victims of musculoskeletal trauma.

Eligibility Criteria

Inclusion Criteria

  • patients 18 and older under the care of the UF Orthopedic Trauma Division admitted to UF Health for trauma resulting in one or more extremity or pelvic fractures requiring surgery will be screened.

Exclusion Criteria

  • patients with Traumatic Brain Injury or a past medical history of bipolar or other mental health conditions on current medical management will be excluded
  • patients unlikely to follow up (live in at a distance from Gainesville, incarcerated etc.) will also be excluded.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04850222). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search